Modulation on immunogenicity by HLA‐B27 subtype polymorphism
- 30 November 1988
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 18 (12) , 1945-1950
- https://doi.org/10.1002/eji.1830181212
Abstract
Cells from the same HLA-B27− individual, PA, were stimulated in vitro in primary mixed lymphocyte culture, with either B*2705+ or B*2704+ lymphoblastoid cell lines, in independent experiments. Cytolytic T lymphocytes (CTL) were cloned at limiting dilution and the clones obtained were screened for anti-B27 alloreactivity. Most of the CTL clones generated against the B*2705+ stimulator cells were directed against the B*2705 +antigen. In contrast, no anti-B27 CTL clones were found among those derived against the B*2704+ stimulator cells. This was not due to a poor cytotoxic response against these cells because a large proportion of the T cell clones derived from this stimulation were cytotoxic. B2704 differs from B705 by only two amino acid changes at positions 77 and 152. Previous studies (Aparacio, P. et al., Eur. J. Immunol. 1988. 18:203) have shown that none of the anti-B*2705 CTL clones derived from donor PA and amenable to detailed characterization cross-reacted with B*2704, suggesting that most of this cytotoxic response was directed against an immunodominant determinant contributed for by residues 77 and/or 152 from B*2705. The present results further suggest that the changes at these positions in B*2704 alter this determinant in such a way that B*2704 becomes less immunogenic for the particular individual PA. Furthermore, a similar poor anti-B*2704 CTL response was obtained from a second B27− responder individual, AE, stimulated with another B2704+ cell line. The single anti-B*2704 CTL clone, 64.8P, isolated from this second individual, displayed an unusual reaction pattern in that it cross-reacted with all B27 subtypes with changes only at or close to positions 77 and 152, including B*2705. Significantly, the only HLA-B27 subtype that was not recognized by CTL 64.8P was B*2703, which differs from B*2705 only at residue 59. This residue is located in the three-dimensional structure at the opposite end from residues 77 and 152 at the surface of the antigen-binding groove of the class I molecule. Thus, the area around residues 77 and 152 is not an essential part of the epitope recognized by CTL 64.8P.Keywords
This publication has 31 references indexed in Scilit:
- HLA monoclonal antibody registry: second listingTissue Antigens, 2008
- Clonal heterogeneity of HLA-B27 cellular allo-recognition. Delineation of immunodominant sitesEuropean Journal of Immunology, 1988
- Molecular analysis of the variant alloantigen HLA-B27d (HLA-B∗2703) identifies a unique single amino acid substitutionHuman Immunology, 1988
- Conventional alloantisera can recognize the same HLA-B27 polymorphism as detected by cytotoxic T lymphocytesHuman Immunology, 1987
- Involvement of the CD4 molecule in a post‐activation event on T cell proliferationEuropean Journal of Immunology, 1987
- Identification of new B27 subtypes (B27C and B27D) prevalent in oriental populationsHuman Immunology, 1986
- Recognition of HLA-B27 and related antigen by a monoclonal antibodyHuman Immunology, 1982
- Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis‐inhibiting effect of 7 monoclonal antibodiesEuropean Journal of Immunology, 1982
- Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donorCell, 1978
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978